Treatment of Lung Cancer by Peptide-Modified Liposomal Irinotecan Endowed with Tumor Penetration and NF-κB Inhibitory Activities-Reference-Cited by-全球学者库

Treatment of Lung Cancer by Peptide-Modified Liposomal Irinotecan Endowed with Tumor Penetration and NF-κB Inhibitory Activities

Published:2020-08-20 Issue:10 Volume:17 Page:3685-3695
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Hu Yang¹,Zhang Yanyu¹,Wang Xiaoyi¹,Jiang Kuan¹,Wang Huan¹,Yao Shengyu¹,Liu Yu¹,Lin Yao-Zhong²,Wei Gang¹³⁴^ORCID,Lu Weiyue¹³^ORCID

Affiliation:

1. Key Laboratory of Smart Drug Delivery, Ministry of Education, Department of Pharmaceutics, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai 201203, China

2. Celtek Bioscience, LLC, 2550 Meridian Boulevard, Suite 200, Franklin, Tennessee 37067, United States

3. The Institutes of Integrative Medicine of Fudan University, Shanghai 200040, China

4. Shanghai Engineering Research Center of ImmunoTherapeutics, Shanghai 201203, China

Funder

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Development Project of Shanghai Peak Disciplines-Integrative Medicine

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c00052

Reference44 articles.

1. Cancer statistics, 2018

2. Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates

3. Lung cancer: current therapies and new targeted treatments

4. HAase-sensitive dual-targeting irinotecan liposomes enhance the therapeutic efficacy of lung cancer in animals

5. Improved Pharmacokinetic and Biodistribution Properties of the Selective Urokinase Inhibitor PAI-2 (SerpinB2) by Site-Specific PEGylation: Implications for Drug Delivery

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lab on chip based self-adjustable liposomes for rapid wound healing: An in depth in vitro, in vivo and higher dose toxicity investigation;Biomaterials Advances;2024-04

2. Dual-targeting tumor cells hybrids derived from Pt(IV) species and NF-κB inhibitors enables cancer therapy through mitochondrial dysfunction and ER stress and overcomes cisplatin resistance;European Journal of Medicinal Chemistry;2024-02

3. Quality by design-assisted development of D-α-tocopherol polyethylene glycol 1000 succinate-incorporated gefitinib-loaded cationic liposome(s);Therapeutic Delivery;2023-12

4. Design strategy and research progress of multifunctional nanoparticles in lung cancer therapy;Expert Opinion on Investigational Drugs;2023-08-03

5. CPP Functionalized Nanoparticles;CPP, Cell-Penetrating Peptides;2023